The U. S. government has taken a surprising step back in its fight against potential health threats. The Department of Health and Human Services (HHS) recently canceled a significant contract with Moderna, a biotech company known for its COVID-19 vaccine. This contract, worth $766 million, was aimed at developing a new vaccine for bird flu, specifically the H5N1 stra...

The U. S. government recently pulled the plug on a major project. The project was to create a vaccine for bird flu. This vaccine was to protect people from flu viruses that could start a pandemic. The government was worried about the safety of the mRNA technology used in the vaccine. The Department of Health and Human Services ended a $766 million deal with Moderna....

The United States government is putting a big chunk of money, about $590 million, into developing a bird flu vaccine. The company Moderna will use this money to keep working on a vaccine that protects against the H5 and H7 types of bird flu. This isn't the first time they're getting help; earlier this year, they got $176 million for the same project. This bird flu v...

In recent months, the bird flu vaccine has sparked a debate in the U. S. , with some people urging President Joe Biden to fast-track its authorization. The vaccine has already been developed for the H5N1 strain, and the government has contracted manufacturers to produce nearly 5 million doses. However, it hasn't yet been approved by the Food and Drug Administration (...

The U.S. government has decided to invest $72 million to prepare bird flu vaccines, ensuring they are ready if needed. This investment, made by the Department of Health & Human Services (HHS), is a precautionary measure. The money will go to CSL Seqirus, Sanofi, and GSK. These pharmaceutical companies will use the funds to fill and finish vaccines, making sure they a...